AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program

Announced positive initial comparative analytical results, confirming identical amino-acid sequencing and highly similar functional ...